NFE2L2 and breast carcinoma: Unlike these works reporting the role of Nrf2 as a mediator of neuroprotection, N-acetylcysteine, another well-known antioxidant and Nrf2 inducer, failed to prevent and control taxane-induced peripheral neuropathy in patients with breast cancer enrolled in a randomized triple-blind clinical trial [40].